Fortress Biotech FBIO
NASDAQ FBIO
$2.03 -0.04 (-1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fortress Biotech (FBIO) Cash from Discontinued Operations (2018)

Updated

Fortress Biotech (FBIO) reported Cash from Discontinued Operations of $5.74 million for Q4 2018, up 157.7% from the prior quarter.

Analysis

Fortress Biotech (FBIO) Cash from Discontinued Operations (2018) Analysis & Trends

For FY2018, Fortress Biotech posted Cash from Discontinued Operations of -$1.79 million.

  • By year, Cash from Discontinued Operations came in at -$4.15 million in FY2017.
  • Per Business Quant data, the three quarters before Q4 2018 came in at $2.23 million (Q3 2018), -$7.37 million (Q2 2018) and -$2.38 million (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Fortress Biotech 67.62 Mn -326.99 Mn 12.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 5.74 Mn
Sep 30, 2018 2.23 Mn
Jun 30, 2018 -7.37 Mn
Mar 31, 2018 -2.38 Mn
API Access

Fortress Biotech Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=FBIO&period=max&api_key=YOUR_API_KEY